Mangoceuticals, Inc. (MGRX) stock
MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$0.15−0.03 (-16.22%)
Close on Nov 13, 2026Market cap $3.34MP/E –Yield –
Mangoceuticals cash
Cash and short-term investments held at the end of each period.
Mangoceuticals's cash was $228.69K at Jun 30, 2026. For fiscal 2025 it was $1.49M, up 2434.1% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49M | +2434.1% |
| FY2024 | Dec 31, 2024 | $58.65K | -92.1% |
| FY2023 | Dec 31, 2023 | $739.01K | +8.2% |
| FY2022 | Dec 31, 2022 | $682.86K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $228.69K | +126.4% |
| Q1 FY2026 | Mar 31, 2026 | $174.56K | +128.2% |
| Q4 FY2025 | Dec 31, 2025 | $1.49M | +2434.1% |
| Q3 FY2025 | Sep 30, 2025 | $481.28K | +551.2% |
| Q2 FY2025 | Jun 30, 2025 | $101.02K | -79.4% |
| Q1 FY2025 | Mar 31, 2025 | $76.50K | +399.8% |
| Q4 FY2024 | Dec 31, 2024 | $58.65K | -92.1% |
| Q3 FY2024 | Sep 30, 2024 | $73.91K | -94.0% |
| Q2 FY2024 | Jun 30, 2024 | $490.24K | -83.4% |
| Q1 FY2024 | Mar 31, 2024 | $15.31K | – |
| Q4 FY2023 | Dec 31, 2023 | $739.01K | +8.2% |
| Q3 FY2023 | Sep 30, 2023 | $1.24M | – |
| Q2 FY2023 | Jun 30, 2023 | $2.95M | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
| Q4 FY2022 | Dec 31, 2022 | $682.86K | – |
See a number that looks wrong?